Gerald Dubois

1.4k total citations
18 papers, 1.0k citations indexed

About

Gerald Dubois is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, Gerald Dubois has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Gerald Dubois's work include Asthma and respiratory diseases (8 papers), Allergic Rhinitis and Sensitization (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Gerald Dubois is often cited by papers focused on Asthma and respiratory diseases (8 papers), Allergic Rhinitis and Sensitization (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Gerald Dubois collaborates with scholars based in United Kingdom, Switzerland and Netherlands. Gerald Dubois's co-authors include Carol E. Jones, Stéphane Ferretti, Olivier Bonneau, Alexandre Trifilieff, René C. Schweizer, P. L. B. Bruijnzeel, Jan‐Willem J. Lammers, Carla A.F.M. Bruijnzeel-Koomen, Tjander Maikoe and Paul J. Coffer and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Gerald Dubois

17 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gerald Dubois

Since Specialization

Citations

This map shows the geographic impact of Gerald Dubois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Dubois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Dubois more than expected).

Fields of papers citing papers by Gerald Dubois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Dubois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Dubois. The network helps show where Gerald Dubois may publish in the future.

Co-authorship network of co-authors of Gerald Dubois

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Dubois. A scholar is included among the top collaborators of Gerald Dubois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Dubois. Gerald Dubois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy 2016 ·Molecular Pharmacology ·David A. Sykes, (unknown), Darren Riddy, (unknown), John Reilly, (unknown), Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois, Steven J. Charlton	54
2	Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Volunteers 2015 ·Clinical Pharmacology in Drug Development ·Veit J. Erpenbeck, Eva Vets, Lien Gheyle, (unknown), Michael Larbig, (unknown), David A. Sandham, Gerald Dubois, (unknown), Paul Goldsmith, H. Weiss	22
3	Safety, tolerability and pharmacokinetics of QAV680, an oral CRTh2 antagonist, in healthy subjects 2014 ·European Respiratory Journal ·Veit J. Erpenbeck, Rainard Fuhr, Gerald Dubois, (unknown)	0
4	QAW039, a slowly dissociating CRTh2 antagonist with potential for improved clinical efficacy 2014 ·European Respiratory Journal ·David A. Sykes, (unknown), Darren Riddy, (unknown), (unknown), (unknown), (unknown), Carsten Bauer, Gerald Dubois, Steven J. Charlton	7
5	Efficacy and safety of 10 day treatment with the CRTh2 antagonist QAV680 evaluated in patients with allergic rhinitis in an environmental exposure chamber 2014 ·European Respiratory Journal ·Veit J. Erpenbeck, (unknown), Piyush M. Patel, (unknown), Gerald Dubois, Ping Zhou, (unknown), Michael Larbig	3
6	Characterization QAW039 and QAV680, two novel, potent and selective CRTh2 antagonists 2014 ·European Respiratory Journal ·(unknown), Zarin Brown, Charles Owen, Gerald Dubois	5
7	QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber 2014 ·European Respiratory Journal ·Veit J. Erpenbeck, Anne Marie Salapatek, Piyush M. Patel, (unknown), Gerald Dubois, (unknown), Michael Larbig	2
8	Safety, tolerability and pharmacokinetics of an oral competitive reversible CRTh2 antagonist, QAW039, in healthy subjects 2014 ·European Respiratory Journal ·Veit J. Erpenbeck, Eva Vets, Lien Gheyle, (unknown), Michael Larbig, (unknown), Gerald Dubois, (unknown)	3
9	Treatment with Anti–Gremlin 1 Antibody Ameliorates Chronic Hypoxia/SU5416–Induced Pulmonary Arterial Hypertension in Mice 2013 ·American Journal Of Pathology ·Loredana Ciuclan, Kelly-Ann Sheppard, Liqun Dong, Daniel Sutton, Nicholas Duggan, Martin Hussey, (unknown), Nicholas W. Morrell, Gábor Járai, Matthew Edwards, Gerald Dubois, Matthew J. Thomas, Gino Van Heeke, Karen England	56
10	Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis 2012 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Nigel J. Pyne, Gerald Dubois, Susan Pyne	55
11	Regulation of Neuregulin 1β1–Induced MUC5AC and MUC5B Expression in Human Airway Epithelium 2009 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), (unknown), (unknown), Peter M. Jones, (unknown), Gerald Dubois, June Giddings, Gino Van Heeke, Carol E. Jones	34
12	The Sphingosine 1-Phosphate Receptor Agonist FTY720 Differentially Affects the Sequestration of CD4+/CD25+ T-Regulatory Cells and Enhances Their Functional Activity 2005 ·The Journal of Immunology ·Elżbieta Sawicka, Gerald Dubois, Gábor Járai, Matthew Edwards, Matthew J. Thomas, Andy Nicholls, Rainer Albert, (unknown), Volker Brinkmann, Christoph Walker	106
13	IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger 2003 ·The Journal of Immunology ·Stéphane Ferretti, Olivier Bonneau, Gerald Dubois, Carol E. Jones, Alexandre Trifilieff	448
14	Adhesion molecule expression on skin endothelia in atopic dermatitis: Effects of TNF-α and IL-4 1998 ·Journal of Allergy and Clinical Immunology ·I. Jolanda M. de Vries, Elisabeth G. Langeveld-Wildschut, Frank C. van Reijsen, Gerald Dubois, (unknown), Ilse C. Bihari, Dick van Wichen, Roel A. de Weger, Edward F. Knol, Theo Thepen, Carla A.F.M. Bruijnzeel-Koomen	57
15	Analysis of Signal Transduction Pathways in Human Eosinophils Activated by Chemoattractants and the T-Helper 2–Derived Cytokines Interleukin-4 and Interleukin-5 1998 ·Blood ·Paul J. Coffer, René C. Schweizer, Gerald Dubois, Tjander Maikoe, Jan‐Willem J. Lammers, Leo Koenderman	97
16	Human Eosinophils Constitutively Express a Functional Interleukin-4 Receptor: Interleukin-4 –Induced Priming of Chemotactic Responses and Induction of PI-3 Kinase Activity 1998 ·American Journal of Respiratory Cell and Molecular Biology ·Gerald Dubois, René C. Schweizer, (unknown), Carla A.F.M. Bruijnzeel-Koomen, P. L. B. Bruijnzeel	43
17	Analysis of Signal Transduction Pathways in Human Eosinophils Activated by Chemoattractants and the T-Helper 2–Derived Cytokines Interleukin-4 and Interleukin-5 1998 ·Blood ·Paul J. Coffer, René C. Schweizer, Gerald Dubois, Tjander Maikoe, Jan‐Willem J. Lammers, Leo Koenderman	8
18	IL-4 Induces Chemotaxis of Blood Eosinophils from Atopic Dermatitis Patients, but Not from Normal Individuals 1994 ·Journal of Investigative Dermatology ·Gerald Dubois, Carla A.F.M. Bruijnzeel-Koomen, P. L. B. Bruijnzeel	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact